Irinotecan Lipid Complex Injection

Major

Irinotecan Lipid Complex Injection Abametapir Increased exposure of CYP3A4 substrate Details Irinotecan Lipid Complex Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Irinotecan Lipid Complex Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Irinotecan Lipid Complex Injection Apalutamide Erleada Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Avacopan Tavneos Increased CYP3A4 substrate exposure Details Irinotecan Lipid Complex Injection Boceprevir Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Carbamazepine Carbatrol Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Ceritinib Zykadia Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Irinotecan Lipid Complex Injection Clarithromycin Biaxin Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Conivaptan Vaprisol Increased CYP3A substrate exposure Details Irinotecan Lipid Complex Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Irinotecan Lipid Complex Injection Enzalutamide Xtandi Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Erythromycin Erythrocin Stearate Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse effects Details Irinotecan Lipid Complex Injection Fedratinib Inrebic Increased CYP3A4 substrate exposure Details Irinotecan Lipid Complex Injection Fexinidazole An increased CYP3A4 substrate exposure Details Irinotecan Lipid Complex Injection Fosnetupitant Increased exposure to chemotherapy agent and increased risk of side effects Details Irinotecan Lipid Complex Injection Fosphenytoin Cerebyx Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Gemfibrozil Lopid Increased irinotecan exposure and an increased irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Idelalisib Zydelig Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Indinavir Increased irinotecan exposure and an increased irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Irinotecan Lipid Complex Injection Ivacaftor Kalydeco Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Ivosidenib Tibsovo Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Letermovir Prevymis Increased CYP3A substrate exposure Details Irinotecan Lipid Complex Injection Lonafarnib Zokinvy Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Lumacaftor Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Mifepristone Korlym Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Mitotane Lysodren Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Nefazodone Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Nelfinavir Viracept Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Netupitant Increased exposure to chemotherapy agent and increased risk of side effects Details Irinotecan Lipid Complex Injection Omaveloxolone Skyclarys Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Irinotecan Lipid Complex Injection Paritaprevir Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Phenobarbital Fidoquel Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Irinotecan Lipid Complex Injection Phenytoin Dilantin Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Posaconazole Noxafil Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Primidone Mysoline Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Irinotecan Lipid Complex Injection Probenecid Increased irinotecan exposure and an increased irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Quizartinib Vanflyta Increased BCRP substrate exposure and an increased risk of BCRP substrate-related adverse reactions Details